- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on HER2-Positive Salivary Gland Carcinomas in Norway
Total 103 results
-
University of BergenUnknown
-
Lovisenberg Diakonale HospitalUniversity of OsloCompletedXerostomia | Terminal IllnessNorway
-
University of TromsoCompletedPeriodontal Diseases | Streptococcal Infections | Dental Plaque | Sialorrhea | Dental Calculus | Lactobacillus InfectionNorway
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingUnresectable Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Metastatic Breast Adenocarcinoma | Metastatic HER2-Positive Breast Carcinoma | Recurrent Breast Adenocarcinoma | Recurrent HER2-Positive Breast Carcinoma | Unresectable HER2-Positive Breast CarcinomaUnited States, Canada
-
University Hospital, AkershusVestre Viken Hospital Trust; NovartisRecruitingBreast Cancer | Locally Advanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Luminal A Breast Cancer | Luminal B Breast CancerNorway
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
Seagen Inc.CompletedTriple Negative Breast Neoplasms | Hormone Receptor Positive Breast Neoplasms | HER2 Positive Breast Neoplasms | HER2 Mutations Breast NeoplasmsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IIIC Breast Cancer AJCC v6 | Stage IV Breast Cancer AJCC v6 and v7United States, Puerto Rico
-
Merck Sharp & Dohme LLCRecruitingCervical Cancer | Small Cell Lung Carcinoma | Neuroendocrine Tumor | Advanced Solid Tumors | Mesothelioma | Vulvar Cancer | Cholangiocarcinoma | Bile Duct Cancer | Endometrial Cancer | Advanced Cancer | Cervical Carcinoma | Endometrial Carcinoma | Thyroid Carcinoma | Thyroid Cancer | Anal Cancer | Colorectal Carcinoma | Carcinoid... and other conditionsCanada, France, Germany, Italy, Mexico, Netherlands, Poland, Russian Federation, Taiwan, United States, Brazil, Colombia, Israel, Korea, Republic of, Norway, Philippines, South Africa, Spain, Australia, Denmark, Chile, Portugal, Peru
-
OncoC4, Inc.National Cancer Institute (NCI)RecruitingCervical Cancer | Small Cell Lung Cancer | Adenoid Cystic Carcinoma | Metastatic Renal Cell Carcinoma | Metastatic Colorectal Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Metastatic Melanoma | Pancreas Cancer | Metastatic... and other conditionsUnited States, Australia
-
University of TromsoCompleted
-
St. Olavs HospitalNorwegian University of Science and TechnologyCompletedCarcinoma, Pancreatic DuctalNorway
-
Helse Stavanger HFUniversity of Oslo; University of StavangerCompletedFatigue | Primary SjogrenNorway
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 | Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7 | Stage IVA Oropharyngeal Squamous... and other conditionsUnited States, Puerto Rico, South Africa
-
Herlev HospitalCelgeneCompletedUnresectable Pancreatic CarcinomaDenmark, Norway
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
Oslo University HospitalEuropean Organisation for Research and Treatment of Cancer - EORTCCompletedQuality of Life | Cancer | Xerostomia | Adverse Effects | Late EffectsNorway, Netherlands, Sweden, Germany, United Kingdom, Greece, France, Israel, Italy, Poland
-
Haukeland University HospitalCompleted
-
Steinar AamdalTerminatedRecurrent Epithelial Ovarian CancerNorway
-
Haukeland University HospitalHelse Stavanger HF; Sorlandet Hospital HFRecruiting
-
Haukeland University HospitalCompleted
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerAustria, Belgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Russian Federation, Korea, Republic of, Hungary, Japan, Mexico, Turkey, China, Malaysia, Spain, Czechia, Portugal, Poland, Norway, Bulgaria, Slovaki... and more
-
Oslo University HospitalUniversity Hospital of North Norway; Helse Stavanger HF; Haukeland University... and other collaboratorsActive, not recruitingChemotherapy Effect | Locally Advanced Pancreatic Adenocarcinoma | Borderline Resectable Pancreatic Adenocarcinoma | PancreatectomyNorway
-
Clavis PharmaCompletedAdvanced Adenocarcinoma of PancreasNorway, Belgium
-
National Cancer Institute (NCI)Southwest Oncology GroupCompletedRecurrent Breast Carcinoma | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
Oslo University HospitalThe Research Council of NorwayRecruitingMesothelioma | Pseudomyxoma Peritonei | Colorectal Carcinoma | Ovarian CarcinomaNorway
-
Active Biotech ABCompletedRenal Cell Carcinoma | Pancreatic Cancer | Non-Small-Cell Lung CarcinomaUnited States, Norway, United Kingdom
-
Nordic Society of Gynaecological Oncology - Clinical...CompletedOvarian Epithelial Cancer RecurrentDenmark, Finland, Norway
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Bayer; United States Department of Defense; Canadian...TerminatedNode Positive HER2 Negative Breast CancerUnited States, Canada, Puerto Rico, Guam
-
Nordic Society of Gynaecological Oncology - Clinical...WithdrawnOvarian CancerNorway, Denmark, Finland
-
Oncoinvent ASActive, not recruitingOvarian Cancer | Peritoneal CarcinomatosisBelgium, Spain, Norway
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Invasive Lobular Breast Carcinoma | Invasive Ductal Breast CarcinomaUnited States, Puerto Rico
-
Kancera ABNordic Society of Gynaecological Oncology - Clinical Trials UnitRecruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerDenmark, Norway, Sweden
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerRecurrent Breast Carcinoma | HER2/Neu Positive | Progesterone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Canada, Puerto Rico, Ireland
-
Nordic Society of Gynaecological Oncology - Clinical...European Network of Gynaecological Oncological Trial Groups (ENGOT); Gynecologic...Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Prognostic Stage I Breast Cancer AJCC v8 | Prognostic Stage II Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Hormone Receptor... and other conditionsUnited States
-
Flemming ForsbergNational Cancer Institute (NCI)RecruitingStage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Stage IIA Pancreatic Cancer AJCC v8 | Stage IIB Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Ductal Adenocarcinoma | Locally Advanced Pancreatic Ductal Adenocarcinoma | Unresectable...United States, Norway
-
AGO Study GroupGERCOR - Multidisciplinary Oncology Cooperative Group; Nordic Society of Gynaecological...CompletedOvarian Cancer | Fallopian Tube CancerNorway, Germany, France, Denmark
-
Erasmus Medical CenterDutch Cancer Society; Dutch Pancreatic Cancer GroupRecruitingPancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Resectable Pancreatic AdenocarcinomaNetherlands, Sweden, Norway
-
GlaxoSmithKlineCompletedSjogren's SyndromeSpain, France, Germany, Netherlands, United Kingdom, Sweden, Argentina, Italy, Canada, Norway
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | HER2/Neu Negative | Breast Adenocarcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States, South Africa
-
Translational Drug DevelopmentTranslational Genomics Research InstituteActive, not recruitingMetastatic Pancreatic Ductal AdenocarcinomaUnited States
-
M.D. Anderson Cancer CenterUnited States Department of DefenseActive, not recruitingOvarian CancerUnited States
-
Nordic Society of Gynaecological Oncology - Clinical...European Organisation for Research and Treatment of Cancer - EORTC; NCIC Clinical...CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerItaly, Canada, Israel, Norway, Belgium, Netherlands, Denmark, Portugal, Spain, United States
-
GlaxoSmithKlineCompletedMeasles | Rubella | Mumps | Measles-Mumps-Rubella VaccineUnited States, Puerto Rico
-
MedImmune LLCCompletedCarcinoma | Metastatic Pancreatic AdenocarcinomaUnited States, Spain, Australia, Norway
-
Hoffmann-La RocheCompletedOvarian CancerFrance, Spain, Brazil, United Kingdom, Netherlands, Italy, Russian Federation, Sweden, Norway
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States, Norway
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedRecurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7 | MET PositiveUnited States
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaboratorsActive, not recruitingRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States, Canada, Switzerland